When caring for a client receiving chlordiazepoxide for alcohol withdrawal, the nurse must recognize that this medication is a long-acting benzodiazepine. Benzodiazepines enhance the effect of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in the central nervous system. While this action is therapeutic for managing withdrawal symptoms such as anxiety and seizure prophylaxis, it also carries a dose-dependent risk of significant central nervous system and respiratory depression.
The assessment finding that requires the most immediate intervention is a respiratory rate of 8 breaths per minute. A normal adult respiratory rate is 12 to 20 breaths per minute. A rate of 8 indicates severe bradypnea, which is a hallmark sign of benzodiazepine toxicity and impending respiratory failure. This constitutes a threat to airway, breathing, and circulation, placing it as the highest priority according to the ABC (Airway, Breathing, Circulation) framework used in nursing triage.
Option 1 (Mild tremors noted in both hands) represents an expected finding during alcohol withdrawal. Chlordiazepoxide is administered specifically to reduce such autonomic hyperactivity symptoms. While the nurse should document and monitor the severity of tremors, this finding does not indicate a life-threatening complication of the medication itself.
Option 2 (Blood pressure reading of 150/90 mmHg) reflects mild hypertension, which is also an expected manifestation of alcohol withdrawal due to increased sympathetic nervous system activity. Although this blood pressure reading is elevated above the normal range of less than 120/80 mmHg, it does not represent a hypertensive crisis or an immediate threat to end-organ function in the context of acute withdrawal management. The nurse would continue to monitor vital signs and the effectiveness of the benzodiazepine therapy.
Option 3 (Client reports feeling mild nausea) is a non-specific symptom that can occur during alcohol withdrawal or as a mild side effect of many medications. While the nurse should provide comfort measures and continue assessment, nausea does not pose an immediate physiological threat and is a lower priority than a critically depressed respiratory drive.
While respiratory depression is the most common serious adverse effect of benzodiazepines requiring acute intervention, the provided literature highlights that severe, potentially lethal adverse reactions can manifest in other organ systems. A case report documented a generalized bullous fixed drug eruption (GBFDE) induced by chlordiazepoxide . GBFDE is a severe cutaneous adverse reaction characterized by vesicles or bullae covering a significant portion of the body surface area. Although rare, this condition can be life-threatening due to complications such as fluid and electrolyte loss, secondary infection, and sepsis. This underscores the critical nursing responsibility to perform comprehensive skin assessments on clients receiving any pharmacotherapy, including chlordiazepoxide. The nurse must not only monitor for the expected therapeutic effects and common side effects like sedation, but also remain vigilant for signs of hypersensitivity reactions, which can range from mild rashes to severe bullous eruptions.
The mechanism behind such reactions involves the drug acting as a hapten, binding to proteins and triggering a T-cell mediated immune response that targets keratinocytes, leading to epidermal necrosis and detachment. While the immediate priority in the presented scenario is the profound respiratory depression, the existence of such severe adverse drug reactions reinforces the need for holistic patient monitoring during medication administration.
A respiratory rate of 8 breaths/min in a client on chlordiazepoxide indicates severe bradypnea and potential benzodiazepine toxicity. This is a direct threat to breathing and takes absolute priority over other withdrawal symptoms.
The nurse must immediately assess oxygen saturation and level of consciousness, prepare to administer the reversal agent flumazenil if protocols allow, and support ventilation with a bag-valve-mask if respirations are inadequate.
Do not confuse expected withdrawal symptoms like tremors or mild hypertension with signs of medication toxicity. Flumazenil administration can precipitate acute withdrawal seizures and must be used cautiously.
학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요.